Herborium Group, Inc. CEO Dr. Agnes P. Olszewski Ph.D., to Be Interviewed on Clear Channel – iHeart Business Talk Radio’s “The Trader’s Network” on January 17th, 2015
Live Interview Airs on the Traders Network Radio Show Hosted by Michael Yorba at 1:00PM ET / 10:00AM PT / 12:00PM CT
FORT LEE, NJ–(Jan 16, 2015) – Herborium Group, Inc. (OTC PINK: HBRM), a novel Botanical Therapeutics® company focused on developing, licensing, and marketing of proprietary, botanical based medicines targeting unmet medical needs, announced today that Chief Executive Officer (CEO) Dr. Agnes P. Olszewski Ph.D. will be interviewed live tomorrow by host Michael Yorba on Clear Channel – iHeart Business Talk Radio’s “The Trader’s Network” Show. In this exclusive interview, Dr. Olszewski will discuss how the company’s innovative business model successfully addresses growing demand of consumers and healthcare professionals to access safe, efficacious, yet safe and all-natural medicinal options for treatment and prevention of selected diseases and health concerns. The company’s unprecedented growth in 2014 as well as plans and opportunities for 2015 will also be discussed. U.S. Shareholders, analysts, industry professionals and all interested parties are encouraged to listen live via Clear Channel’s nationally syndicated iHeart Radio stream.
Date: January 17, 2015
Start Time: 1:00pm ET |10:00am PT | 12:00pm CT (U.S.)
Network: Clear Channel – iHeart
Station: DFW 1190AM
KFXR Show: The Trader’s Network
Host: Michael Yorba
Live iHeart Radio Stream: http://www.iheart.com/live/4276/?autoplay=true
About Herborium Group, Inc.
Herborium Group, Inc. is a novel Botanical Therapeutics® company focused on developing, licensing, and marketing of proprietary, botanical based medicinal products, targeting unmet medical needs. The Company responds to both consumers and healthcare professionals demand for safe, efficacious, all-natural medicinal options for treatment and prevention of selected diseases and health concerns.
The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The potential for this market assesses for over $125 billion in the USA, Canada and UK alone.
This new market is presently positioned for exponential growth since it represents a compelling response to changing needs of a healthcare sector. For the industry, botanical therapeutics® provide a value-added approach based on product differentiation, higher profit margins, and intellectual property protection with a lower risk and regulatory burden and lower cost. Nutraceuticals (supplements) face increasing FDA and market scrutiny, with massive competitive pressures. To meet the needs of this new growing market opportunity for a diverse spectrum of botanically based drugs, along with complementary and non-traditional therapies; Herborium introduces its own Botanical Therapeutics® defined as “bridge products,” an emerging category of natural medicines with clinically and scientifically validated efficacy and safety.
Botanical Therapeutics® represents benefits and attributes of both aforementioned traditional sectors. Botanical Therapeutics® bring the intellectual property value, posology, clinical validation and rapid market entry while maintaining a safety profile of botanical ingredients and offering the benefits of preventive medicine and cost containment. For its own Botanical Therapeutics® the Company adopts clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium harvests its proprietary therapeutic candidates from so called “ethnic” medicinal sources such as Traditional Chinese Medicine (TCM) with initial confirmatory data and utilizes Western regulatory, clinical and marketing strategies to successfully introduce the products to the Western and progressive global markets. This strategy serves to mitigate risk in the product development and marketing strategies. The Company secured a pipeline of botanical ingredient-based products in the areas of Dermatologic, Women’s Health and Men’s Health including selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, surgical procedures, and other problems. Short term product portfolio also includes all herbal Energy and Stress Management formula free of caffeine, sugar, Vit. B complex and amino acids. The longer-term pipeline includes Prostate Health (BPH) and Liver Diseases, as well as product extensions in existing product categories and the anti-infectious product candidate focused on antibiotic resistant infections. Herborium Managements represents a unique blend of expertise with over 50 years of successful business dealings in marketing healthcare and consumer products, an exceptional track record in pharmacology and drug development, clinical testing and regulatory affairs in the US and Europe, supported by high standards, know how in herbal science and formulation and global outreach. Herborium presently sells its products in the United States, the United Kingdom, Canada and continental Europe through a network of distributors, specialty retailers, and e-commerce. With initial seed investment brought to the Company by Friends and Family and a small professional round, the Company has developed and deployed a solid and innovative business model that already brings rapidly growing revenues and is ideally positioned for exponential growth in the near future. Down economic times are actually realizing an additional pressure on the sector, and both consumers and insurance companies look for safer and more affordable healthcare options.
About CEO Dr. Agnes P. Olszewski Ph.D.
Western medical science has revolutionized the treatment of diseases worldwide, offering a science-based, clinically tested approach and enabling patients to routinely manage diseases that used to be considered a death sentence. But centuries before Anthony Leeuwenhoek spotted bacteria through a microscope, traditional communities in Asia, South America, Africa and even Europe were using herbal compounds to provide relief for medical conditions and promote wellness. Dr. Agnes P. Olszewski, a U.S. citizen who grew up in Europe and gained extensive experience with traditional medicine as a business consultant in Asia, is in a unique position to appreciate the benefits of a blended approach to wellness that draws on the wisdom of both modern and ancient traditions. That’s what led her to found Herborium Group (HBRM), a publicly traded Botanical Therapeutics® company, since 2006.
With both a PhD and an MBA, Dr. Olszewski developed her passion for providing all-natural alternatives and complementary botanical ingredients-based therapies that blend science and nature during an over 20-year strategic management and consulting career that included extensive work in the development and marketing of consumer products, including botanical medicines, beauty and health supplements and nutrition products in the U.S., Europe and China. Her experience includes work on a high-profile biotechnology joint venture in China, where she cultivated relationships with key Chinese business and government officials. Dr. Olszewski also served as Director of the Institute for International Business at Seton Hall University and as Professor of Marketing and International Business prior to founding Herborium.
Since launching Herborium Group, Dr. Olszewski and her team have focused on developing products that combine the best Western and traditional medicine have to offer, meeting unmet wellness needs in the U.S. and Europe. Leveraging the treasure trove of traditional medicines that have been proven effective over the centuries and applying modern scientific standards in development and testing, Herborium currently offers a range of Botanical Therapeutics® that address a variety of conditions, including acne and the controlling symptoms of rosacea, men’s and women’s sexual health, energy and stress management and in an foreseeable future, Prostate Health.
Presently, the company’s flagship product is AcnEase®, all herbal dermatologic that treats the root cause of acne — an overproduction of sebum (skin oil) by sebaceous glands, which leads to localized inflammation and scarring — instead of just acne the symptoms. AcnEase® tablets, a proprietary herbal compound that restores balance and skin health, is up to 96% effective in treating acne and the controlling symptoms of rosacea and works for people who suffer from acne of any type at any age, regardless of gender, skin type and color of complexion. Herborium’s Women and Men Sexual formulas and Energy & Stress Management formula are in line to market.
In addition to developing botanical-based medicinal products, Dr. Olszewski is also passionate about educating the public about the benefits — and potential drawbacks — of natural medicines. She is a member of the GLG Council and a frequent speaker and writer on the topics of integrated and personalized medicine, natural remedies, wellness and prevention, nutraceutical products and global marketing strategies in a sector. Find out more about Dr. Olszewski and the Herborium Group at www.herborium.com.
About Clear Channel
Clear Channel’s Media and Entertainment division has the largest reach of any radio or television outlet in America with 243 million monthly listeners. It serves 150 cities through 850 owned radio stations in the U.S., as well as more than 140 stations in New Zealand and Australia. www.clearchannel.com.
About the Traders Network Show
For the past six years “The Traders Network Show” has been hosted and broadcasted live daily on Clear Channel DFW 1190AM KFXR from 6am – 7:30am and 2pm – 3pm CT, Monday-Friday. Host Michael Yorba interviews the front-page Titans about the latest in capital markets, CEO milestones, trading tools, real estate acquisitions and market trends. Learn how the experts use risk management techniques to build fully diversified portfolios and what it takes to put up big board earnings. It’s a fast moving, high-energy show that presents stocks, commodities, bonds, forex, derivatives, real estate, political trends, technology trends, crowd funding and impact investment insights in a new light and keeps the audience asking for more… shift your thinking and join us as we deliver “tomorrow’s ideas today” on iHeart Radio and Clear Channel’s The Traders Network Show.
PR & Media Contact:
Matt Bird, CEO
C: +1 (646) 401-4499
For more information visit: commpro.com | Twitter | LinkedIn | Facebook
Sorry, the comment form is closed at this time.